These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 9853134)
1. Simultaneous radiotherapy for prostate cancer: 125I prostate implant followed by external-beam radiation. Critz FA; Levinson AK; Williams WH; Holladay CT; Griffin VD; Holladay DA Cancer J Sci Am; 1998; 4(6):359-63. PubMed ID: 9853134 [TBL] [Abstract][Full Text] [Related]
2. Candidates for prostate radioactive seed implantation treated by external beam radiotherapy. Seung SK; Kroll S; Wilder RB; Posner MD; Roach M Cancer J Sci Am; 1998; 4(3):168-74. PubMed ID: 9612598 [TBL] [Abstract][Full Text] [Related]
3. Prostate-specific antigen relapse-free survival in patients with localized prostate cancer treated by brachytherapy. Joseph J; Al-Qaisieh B; Ash D; Bottomley D; Carey B BJU Int; 2004 Dec; 94(9):1235-8. PubMed ID: 15610096 [TBL] [Abstract][Full Text] [Related]
4. Surgery versus implant for early prostate cancer: results from a single institution, 1992-2005. Colberg JW; Decker RH; Khan AM; McKeon A; Wilson LD; Peschel RE Cancer J; 2007; 13(4):229-32. PubMed ID: 17762756 [TBL] [Abstract][Full Text] [Related]
5. Prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapy. Eggener SE; Roehl KA; Yossepowitch O; Catalona WJ J Urol; 2006 Oct; 176(4 Pt 1):1399-403. PubMed ID: 16952643 [TBL] [Abstract][Full Text] [Related]
6. Prostate specific antigen bounce after simultaneous irradiation for prostate cancer: the relationship to patient age. Critz FA; Williams WH; Levinson AK; Benton JB; Schnell FJ; Holladay CT; Shrake PD J Urol; 2003 Nov; 170(5):1864-7. PubMed ID: 14532794 [TBL] [Abstract][Full Text] [Related]
7. Prostate specific antigen nadir achieved by men apparently cured of prostate cancer by radiotherapy. Critz FA; Levinson AK; Williams WH; Holladay CT; Griffin VD; Holladay DA J Urol; 1999 Apr; 161(4):1199-203; discussion 1203-5. PubMed ID: 10081869 [TBL] [Abstract][Full Text] [Related]
8. Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up. Ragde H; Korb LJ; Elgamal AA; Grado GL; Nadir BS Cancer; 2000 Jul; 89(1):135-41. PubMed ID: 10897010 [TBL] [Abstract][Full Text] [Related]
9. Perineural invasion is not predictive of biochemical outcome following prostate brachytherapy. Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E Cancer J; 2001; 7(5):404-12. PubMed ID: 11693899 [TBL] [Abstract][Full Text] [Related]
10. Improved biochemical disease-free survival of men younger than 60 years with prostate cancer treated with high dose conformal external beam radiotherapy. Zelefsky MJ; Marion C; Fuks Z; Leibel SA J Urol; 2003 Nov; 170(5):1828-32. PubMed ID: 14532785 [TBL] [Abstract][Full Text] [Related]
11. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995. Kupelian P; Kuban D; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):415-9. PubMed ID: 15667961 [TBL] [Abstract][Full Text] [Related]
12. Unification of a common biochemical failure definition for prostate cancer treated with brachytherapy or external beam radiotherapy with or without androgen deprivation. Fitch DL; McGrath S; Martinez AA; Vicini FA; Kestin LL Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1430-9. PubMed ID: 16765527 [TBL] [Abstract][Full Text] [Related]
13. Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors. Martinez A; Gonzalez J; Spencer W; Gustafson G; Kestin L; Kearney D; Vicini FA J Urol; 2003 Mar; 169(3):974-9; discussion 979-80. PubMed ID: 12576825 [TBL] [Abstract][Full Text] [Related]
14. Effect of cigarette smoking on biochemical outcome after permanent prostate brachytherapy. Merrick GS; Butler WM; Wallner KE; Galbreath RW; Lief JH; Adamovich E Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1056-62. PubMed ID: 15001245 [TBL] [Abstract][Full Text] [Related]
16. Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer. Critz FA; Williams WH; Benton JB; Levinson AK; Holladay CT; Holladay DA J Urol; 2000 Apr; 163(4):1085-9. PubMed ID: 10737471 [TBL] [Abstract][Full Text] [Related]
17. Population-based study of biochemical and survival outcomes after permanent 125I brachytherapy for low- and intermediate-risk prostate cancer. Morris WJ; Keyes M; Palma D; Spadinger I; McKenzie MR; Agranovich A; Pickles T; Liu M; Kwan W; Wu J; Berthelet E; Pai H Urology; 2009 Apr; 73(4):860-5; discussion 865-7. PubMed ID: 19168203 [TBL] [Abstract][Full Text] [Related]
18. Influence of body mass index on biochemical outcome after permanent prostate brachytherapy. Merrick GS; Butler WM; Wallner KE; Galbreath RW; Allen Z; Lief JH; Adamovich E Urology; 2005 Jan; 65(1):95-100. PubMed ID: 15667872 [TBL] [Abstract][Full Text] [Related]
19. Long-term prostate cancer control using palladium-103 brachytherapy and external beam radiotherapy in patients with a high likelihood of extracapsular cancer extension. Dattoli M; Wallner K; True L; Cash J; Sorace R Urology; 2007 Feb; 69(2):334-7. PubMed ID: 17320673 [TBL] [Abstract][Full Text] [Related]
20. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation. Demanes DJ; Brandt D; Schour L; Hill DR Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]